Pfizer, Ranbaxy prevail in antitrust fight over Lipitor generics

Pfizer ($PFE) and Ranbaxy Laboratories persuaded a U.S. judge to toss out an antitrust lawsuit accusing them of conspiring to delay generic versions of the cholesterol-fighting blockbuster Lipitor. Report